Folate Analog Metabolic Inhibitor [EPC]

335085 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 60570
1 RHEUMATOID ARTHRITIS 31821
2 ARTHRALGIA 29030
3 PAIN 28585
4 FATIGUE 22737
5 OFF LABEL USE 21419
6 NAUSEA 19054
7 JOINT SWELLING 17903
8 HEADACHE 16183
9 DRUG INTOLERANCE 15825
See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3332 0.9258
1 SWOLLEN JOINT COUNT INCREASED 787 0.9130
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 259 0.8750
3 RHEUMATOID FACTOR POSITIVE 2678 0.8235
4 PEMPHIGUS 5800 0.7728
5 RHEUMATIC FEVER 933 0.7685
6 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1487 0.7380
7 C-REACTIVE PROTEIN ABNORMAL 2561 0.6940
8 SYNOVITIS 8687 0.6916
9 HAND DEFORMITY 5484 0.6533
See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]